Abstract

Studies in patients have suggested that the clinical phenotypes of some mitochondrial diseases might transit from one disease to another (e.g., Pearson syndrome [PS] to Kearns-Sayre syndrome) in single individuals carrying mitochondrial (mt) DNA with a common deletion (∆mtDNA), but there is no direct experimental evidence for this. To determine whether ∆mtDNA has the pathologic potential to induce multiple mitochondrial disease phenotypes, we used trans-mitochondrial mice with a heteroplasmic state of wild-type mtDNA and ∆mtDNA (mito-mice∆). Late-stage embryos carrying ≥50% ∆mtDNA showed abnormal hematopoiesis and iron metabolism in livers that were partly similar to PS (PS-like phenotypes), although they did not express sideroblastic anemia that is a typical symptom of PS. More than half of the neonates with PS-like phenotypes died by 1 month after birth, whereas the rest showed a decrease of ∆mtDNA load in the affected tissues, peripheral blood and liver, and they recovered from PS-like phenotypes. The proportion of ∆mtDNA in various tissues of the surviving mito-mice∆ increased with time, and Kearns-Sayre syndrome−like phenotypes were expressed when the proportion of ∆mtDNA in various tissues reached >70–80%. Our model mouse study clearly showed that a single ∆mtDNA was responsible for at least two distinct disease phenotypes at different ages and suggested that the level and dynamics of ∆mtDNA load in affected tissues would be important for the onset and transition of mitochondrial disease phenotypes in mice.

Highlights

  • IntroductionPathogenic mtDNAs having a large-scale deletion (ΔmtDNA), called the “common deletion,” or a point mutation, induce defects of mitochondrial oxidative phosphorylation (mitochondrial respiration defects) and manifest as a wide variety of mitochondrial diseases (Larsson and Clayton 1995; Wallace 1999)

  • Pathogenic mtDNAs having a large-scale deletion (ΔmtDNA), called the “common deletion,” or a point mutation, induce defects of mitochondrial oxidative phosphorylation and manifest as a wide variety of mitochondrial diseases (Larsson and Clayton 1995; Wallace 1999)

  • The mito-miceΔ, would provide the direct experiment evidence whether a single ΔmtDNA could cause the onset and transition of different mitochondrial disease phenotypes. By using these mito-miceΔ, we investigated that ΔmtDNA possessed a pathogenic potential for the onset of two distinct phenotypes of mitochondrial diseases, PS-like and KSS-like phenotypes, early in life and in midlife (6 months of age), respectively

Read more

Summary

Introduction

Pathogenic mtDNAs having a large-scale deletion (ΔmtDNA), called the “common deletion,” or a point mutation, induce defects of mitochondrial oxidative phosphorylation (mitochondrial respiration defects) and manifest as a wide variety of mitochondrial diseases (Larsson and Clayton 1995; Wallace 1999). It has been well documented that ΔmtDNA is responsible for three clinical phenotypes of mitochondrial diseases: Kearns–Sayre syndrome (KSS), progressive external ophthalmoplegia, and Pearson syndrome (PS) KSS is usually sporadic and is characterized by early onset (,20 years of age), lactic acidosis, chronic progressive external ophthalmoplegia, pigmentary retinopathy, heart block, diabetes, deafness, cerebellar abnormalities, and renal failure. Progressive external ophthalmoplegia is mainly a skeletal muscle disorder and is characterized by late-onset progressive external ophthalmoplegia, lactic acidosis, myopathy, and exercise intolerance. Larsson et al (1990) suggest that the transition of disease phenotypes is governed by the fractional concentration of ΔmtDNA in various tissues; there is currently no experimental

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call